【美股财报】Clearmind Medicine Inc 2025年年度报告和过渡报告.pdf

3D MEDICINES二零二三年年报

Editas Medicine Inc 2025年季度报告

Medicine shortages: EFPIA proposal for action

Disc Medicine Inc 2024年度报告

Praxis Precision Medicines Inc 2025年季度报告

Position on the Use of Artificial Intelligence in the Medicinal Product Lifecycle

3D MEDICINES-B二零二二年年报

Blueprint Medicines Corp 2025年季度报告

Harnessing the Benefits of Externally Controlled Clinical Trials (ECTs) to Accelerate Development of Better Medicines

How Off-Label Use of Medicines Drives Health-Care Use and Disability